Internal Limiting Membrane Peeling in Retinal Detachment Surgery
IMPURITY
1 other identifier
interventional
126
0 countries
N/A
Brief Summary
Despite advances in surgical techniques over the recent decades, proliferative vitreoretinopathy (PVR) remains the main obstacle to successful rhegmatogenous retinal detachment (RRD) repair, accounting for nearly 75% of all primary surgical failures. It is characterized by the growth and contraction of cellular membranes within the vitreous cavity and on both surfaces of the detached retina as well as intraretinal fibrosis. The Retina Society classification, modified in 1991 and currently the most widely used, divided PVR into three grades. Grade A is limited to the presence of vitreous haze and pigment clumps. Grade B includes rolled or irregular edges of tear and/or inner retinal surface wrinkling with possible retinal stiffness and vessel tortuosity. Grade C is defined as the presence of full-thickness fixed retinal folds and is further subdivided based on the number of hours involved and the location. Recently, Foveau et al., in a retrospective comparative case series, have demonstrated that performing internal limiting membrane (ILM) peeling during RRD surgery may increase the anatomical success rate for this indication. The aim of this multi-center, prospective, randomized controlled clinical trial study is to evaluate the effectiveness of ILM peeling on surgical outcomes in patients with primary macula-off RRD complicated by grade B PVR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
September 9, 2022
CompletedFirst Posted
Study publicly available on registry
September 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
September 13, 2022
July 1, 2022
4 years
September 9, 2022
September 9, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Primary anatomical success rate
Primary retinal reattachment rate
12 months after surgery
Secondary Outcomes (7)
Functional outcomes #1
12 months after surgery
Functional outcomes #2
12 months after surgery
Anatomical outcomes #1
12 months after surgery
Anatomical outcomes #2
12 months after surgery
Anatomical outcomes #3
12 months after surgery
- +2 more secondary outcomes
Study Arms (2)
Control group
OTHERThe internal limiting membrane is not removed
Intervention group
OTHERThe internal limiting membrane of the posterior pole is removed
Interventions
Vitrectomy and gas tamponade without internal limiting membrane peeling
Vitrectomy, internal limiting membrane peeling and gas tamponade
Eligibility Criteria
You may qualify if:
- Patients older than 18 years old
- With macula-off retinal detachment complicated by grade B proliferative vitreoretinopathy
You may not qualify if:
- Underage patients
- History of retinal detachment
- History of intraocular surgery (except for cataract surgery)
- Traumatic retinal detachment
- Macular hole-associated retinal detachment
- Concurrent macular disease (diabetic maculopathy, age-related macular degeneration)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (6)
Borowicz D, Nowomiejska K, Nowakowska D, Brzozowska A, Toro MD, Avitabile T, Junemann AG, Rejdak R. Functional and morphological results of treatment of macula-on and macula-off rhegmatogenous retinal detachment with pars plana vitrectomy and sulfur hexafluoride gas tamponade. BMC Ophthalmol. 2019 May 24;19(1):118. doi: 10.1186/s12886-019-1120-3.
PMID: 31126280RESULTCharteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol. 1995 Oct;79(10):953-60. doi: 10.1136/bjo.79.10.953. No abstract available.
PMID: 7488586RESULTEissa MGAM, Abdelhakim MASE, Macky TA, Khafagy MM, Mortada HA. Functional and structural outcomes of ILM peeling in uncomplicated macula-off RRD using microperimetry & en-face OCT. Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):249-257. doi: 10.1007/s00417-017-3875-7. Epub 2018 Jan 3.
PMID: 29299741RESULTFallico M, Russo A, Longo A, Pulvirenti A, Avitabile T, Bonfiglio V, Castellino N, Cennamo G, Reibaldi M. Internal limiting membrane peeling versus no peeling during primary vitrectomy for rhegmatogenous retinal detachment: A systematic review and meta-analysis. PLoS One. 2018 Jul 19;13(7):e0201010. doi: 10.1371/journal.pone.0201010. eCollection 2018.
PMID: 30024983RESULTFoveau P, Leroy B, Berrod JP, Conart JB. Internal Limiting Membrane Peeling in Macula-off Retinal Detachment Complicated by Grade B Proliferative Vitreoretinopathy. Am J Ophthalmol. 2018 Jul;191:1-6. doi: 10.1016/j.ajo.2018.03.037. Epub 2018 Apr 3.
PMID: 29621507RESULTSteel DH, Joussen AM, Wong D. ILM peeling in rhegmatogenous retinal detachment; does it improve the outcome? Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):247-248. doi: 10.1007/s00417-017-3876-6. Epub 2017 Dec 27. No abstract available.
PMID: 29282562RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Baptiste CONART, Prof
Brabois Hospital, Nancy, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2022
First Posted
September 13, 2022
Study Start
September 1, 2022
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
September 13, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share